New technologies are increasingly being assessed through the value of their contribution. In this track, it will be explored how value is understood in different regions and by different stakeholders such as regulators, pharma, HTA organizations/payers, providers, and patients, and how the creation of value may lead to access. The track also explores different ways of managing uncertainties in value demonstration.

Who is This Track Designed For?

Professionals involved in patient access, market access, regulatory intelligence, health technology assessment, outcomes research, health economics, pricing and reimbursement, and regulatory strategy, from the industry as well as from governmental or public organizations and academics.